Tricuspid stenosis cardiac catheterization: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 8: | Line 8: | ||
During diastole, there is a gradient between the [[right atrial]] ([[RA]]) and right ventricular ([[RV]]) diastolic pressure (RA is higher than RVEDP). A large [[a wave]] may be seen on the [[RA]] tracing. | During diastole, there is a gradient between the [[right atrial]] ([[RA]]) and right ventricular ([[RV]]) diastolic pressure (RA is higher than RVEDP). A large [[a wave]] may be seen on the [[RA]] tracing. | ||
In the older pre-surgery population, cardiac catherization may be necessary in order to assess concomitant artery disease. | |||
* | Cathertization of the right heart is useful for the evaluation of: | ||
* | * The gradient across the valve and valve area | ||
* Evaluation of associated congenital defects | |||
Cathertization of the left heart is useful for the assessment of hemodynamic changes related to the [[aortic valve|aortic]] and [[mitral valve]]s in patients with [[rheumatic heart disease]]. | |||
==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= | issue= | pages= | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref>== | ==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= | issue= | pages= | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref>== | ||
{|class="wikitable" | {|class="wikitable" | ||
Revision as of 23:24, 17 September 2014
|
Tricuspid stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid stenosis cardiac catheterization On the Web |
|
American Roentgen Ray Society Images of Tricuspid stenosis cardiac catheterization |
|
Risk calculators and risk factors for Tricuspid stenosis cardiac catheterization |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
While echocardiography remains the diagnostic imaging modality of choice, cardiac catheterization is useful to evaluate tricuspid stenosis when the results of the non-invasive testing are insufficient, particularly among patients who are being evaluated for other conditions such as mitral stenosis and pulmonary hypertension.
Cardiac Catheterization
During diastole, there is a gradient between the right atrial (RA) and right ventricular (RV) diastolic pressure (RA is higher than RVEDP). A large a wave may be seen on the RA tracing.
In the older pre-surgery population, cardiac catherization may be necessary in order to assess concomitant artery disease.
Cathertization of the right heart is useful for the evaluation of:
- The gradient across the valve and valve area
- Evaluation of associated congenital defects
Cathertization of the left heart is useful for the assessment of hemodynamic changes related to the aortic and mitral valves in patients with rheumatic heart disease.
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]
| Class IIb |
| "1. Invasive hemodynamic assessment of severity of TS may be considered in symptomatic patients when clinical and noninvasive data are discordant. (Level of Evidence: C)" |
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.